GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin.
Schiariti
Michele
M
S. Anna Hospital, Catanzaro University "La Sapienza", Rome, Italy.
Saladini
Angela
A
Papalia
Francesco
F
Grillo
Placido
P
Nesta
Cristina
C
Cuturello
Domenico
D
Missiroli
Bindo
B
Puddu
Paolo Emilio
PE